The following is true of multidrug therapy of leprosy
except:
A. It has been highly successful in paucibacillary but not in multibacillary cases
B. Relapse rate is very low in both paucibacillary and multibacillary cases
C. No resistance to rifampin develops despite
its use once a month
D. Prevalence of lepra reaction is not higher
compared to dapsone monotherapy
except:
A. It has been highly successful in paucibacillary but not in multibacillary cases
B. Relapse rate is very low in both paucibacillary and multibacillary cases
C. No resistance to rifampin develops despite
its use once a month
D. Prevalence of lepra reaction is not higher
compared to dapsone monotherapy